The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
Abstract
The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic nanoparticles that interface with biological systems have recently attracted widespread interest in the fields of biology and medicine. The new term nanomedicine has been used recently. Nanoparticles are considered to have the potential as novel intravascular or cellular probes for both diagnostic (imaging) and therapeutic purposes (drug/gene delivery), which is expected to generate innovations and play a critical role in medicine. Target‐specific drug/gene delivery and early diagnosis in cancer treatment is one of the priority research areas in which nanomedicine will play a vital role. Some recent breakthroughs in this field recently also proved this trend. Nanoparticles for drug delivery and imaging have gradually been developed as new modalities for cancer therapy and diagnosis. In this article, we review the significance and recent advances of gene/drug delivery to cancer cells, and the molecular imaging and diagnosis of cancer by targeted functional nanoparticles. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., & Bruchez, M. P. (2003) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
Hardman, R. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8284 · Cited by 2,303
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Long-term multiple color imaging of live cells using quantum dot bioconjugates
Jaiswal, J. K., Mattoussi, H., Mauro, J. M., & Simon, S. M. (2003) · Nature Biotechnology · doi:10.1038/nbt767 · Cited by 1,999
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C., Lowery, A., Halas, N., West, J., & Drezek, R. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Iron oxide MR contrast agents for molecular and cellular imaging
Bulte, J. W. M., & Kraitchman, D. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.924 · Cited by 1,500
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
The potential risks of nanomaterials: a review carried out for ECETOC.
Borm, P. J. A., Robbins, D. J., Haubold, S., Kuhlbusch, T. A. J., Fissan, H. J., Donaldson, K., Schins, R. P. F., Stone, V., Kreyling, W. G., Lademann, J. M., et al. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-11 · Cited by 1,379
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
In vivo molecular and cellular imaging with quantum dots
Gao, X., Yang, L., Petros, J. A., Marshall, F. F., Simons, J. W., & Nie, S. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.11.003 · Cited by 1,211
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005) · Nature · doi:10.1038/nature03794 · Cited by 945
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Rabin, O., Manuel Perez, J., Grimm, J., Wojtkiewicz, G., & Weissleder, R. (2006) · Nature Materials · doi:10.1038/nmat1571 · Cited by 942
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 850
Nanotechnology: convergence with modern biology and medicine
Roco, M. C. (2003) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(03)00068-5 · Cited by 763
Conjugation of Biomolecules with Luminophore-Doped Silica Nanoparticles for Photostable Biomarkers
Santra, S., Zhang, P., Wang, K., Tapec, R., & Tan, W. (2001) · Analytical Chemistry · doi:10.1021/ac010406+ · Cited by 756
Nanoscience, Nanotechnology, and Chemistry
Whitesides, G. M. (2005) · Small · doi:10.1002/smll.200400130 · Cited by 719
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Koo, O. M., Rubinstein, I., & Onyuksel, H. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.06.004 · Cited by 718
Voura, E. B., Jaiswal, J. K., Mattoussi, H., & Simon, S. M. (2004) · Nature Medicine · doi:10.1038/nm1096 · Cited by 688
Nanotechnology for the biologist
McNeil, S. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205074 · Cited by 613
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Langer, R. (2001) · Science · doi:10.1126/science.1063273 · Cited by 579
The Pulmonary Toxicology of Ultrafine Particles
Donaldson, K., Brown, D., Clouter, A., Duffin, R., MacNee, W., Renwick, L., Tran, L., & Stone, V. (2002) · Journal of Aerosol Medicine · doi:10.1089/089426802320282338 · Cited by 557
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Enhancement of transfection by physical concentration of DNA at the cell surface
Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/78523 · Cited by 541
Roy, I., Ohulchanskyy, T. Y., Bharali, D. J., Pudavar, H. E., Mistretta, R. A., Kaur, N., & Prasad, P. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408039101 · Cited by 457
Bionanotechnology based on silica nanoparticles
Tan, W., Wang, K., He, X., Zhao, X. J., Drake, T., Wang, L., & Bagwe, R. P. (2004) · Medicinal Research Reviews · doi:10.1002/med.20003 · Cited by 457
Tkachenko, A. G., Xie, H., Liu, Y., Coleman, D., Ryan, J., Glomm, W. R., Shipton, M. K., Franzen, S., & Feldheim, D. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034189q · Cited by 448
Self-citationHu, F. Q., Wei, L., Zhou, Z., Ran, Y. L., Li, Z., & Gao, M. Y. (2006) · Advanced Materials · doi:10.1002/adma.200600385 · Cited by 444
Biomedical Applications and Potential Health Risks of Nanomaterials: Molecular Mechanisms
Lanone, S., & Boczkowski, J. (2006) · Current Molecular Medicine · doi:10.2174/156652406778195026 · Cited by 434
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Nanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379
Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border
Yancopoulos, G. D., Klagsbrun, M., & Folkman, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81426-9 · Cited by 379
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 371
Targeting cancer cells: magnetic nanoparticles as drug carriers
Alexiou, C., Schmid, R. J., Jurgons, R., Kremer, M., Wanner, G., Bergemann, C., Huenges, E., Nawroth, T., Arnold, W., & Parak, F. G. (2006) · European Biophysics Journal · doi:10.1007/s00249-006-0042-1 · Cited by 362
Nanomedicines and nanotoxicology: some physiological principles
Garnett, M. C., & Kallinteri, P. (2006) · Occupational Medicine · doi:10.1093/occmed/kql052 · Cited by 352
Advancing the field of drug delivery
Moses, M. A., Brem, H., & Langer, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00276-9 · Cited by 343
Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery
Liu, Y., Miyoshi, H., & Nakamura, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.018 · Cited by 319
Self-citationAdhesion events in angiogenesis
Eliceiri, B. P., & Cheresh, D. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00252-0 · Cited by 287
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles
Lian, W., Litherland, S. A., Badrane, H., Tan, W., Wu, D., Baker, H. V., Gulig, P. A., Lim, D. V., & Jin, S. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.08.005 · Cited by 270
Hoshino, A., Hanaki, K.-I., Suzuki, K., & Yamamoto, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.185 · Cited by 267
Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles
Schmieder, A. H., Winter, P. M., Caruthers, S. D., Harris, T. D., Williams, T. A., Allen, J. S., Lacy, E. K., Zhang, H., Scott, M. J., Hu, G., et al. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20391 · Cited by 246
Nanobiotechnology: the promise and reality of new approaches to molecular recognition
Fortina, P., Kricka, L. J., Surrey, S., & Grodzinski, P. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.02.007 · Cited by 241
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
Schülke, N., Varlamova, O. A., Donovan, G. P., Ma, D., Gardner, J. P., Morrissey, D. M., Arrigale, R. R., Zhan, C., Chodera, A. J., Surowitz, K. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735443100 · Cited by 232
Controlled release systems for DNA delivery
Pannier, A. K., & Shea, L. D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.03.020 · Cited by 227
Targeted nanoparticles for detecting and treating cancer
Sunderland, C. J., Steiert, M., Talmadge, J. E., Derfus, A. M., & Barry, S. E. (2006) · Drug Development Research · doi:10.1002/ddr.20069 · Cited by 200
Fahmy, T. M., Samstein, R. M., Harness, C. C., & Mark Saltzman, W. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.025 · Cited by 194
Fahmy, T. M., Fong, P. M., Goyal, A., & Saltzman, W. M. (2005) · Materials Today · doi:10.1016/s1369-7021(05)71033-6 · Cited by 192
Polymeric Nanoparticle Preparation that Eradicates Tumors
McCarthy, J. R., Perez, J. M., Brückner, C., & Weissleder, R. (2005) · Nano Letters · doi:10.1021/nl0519229 · Cited by 192
Advanced Drug Delivery Systems That Target The Vascular Endothelium
Ding, B.-S. (2006) · Molecular Interventions · doi:10.1124/mi.6.2.7 · Cited by 182
A self-assembled, modular DNA delivery system mediated by silica nanoparticles
Luo, D., Han, E., Belcheva, N., & Saltzman, W. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.019 · Cited by 168
Quantum dots finally come of age
Jovin, T. M. (2003) · Nature Biotechnology · doi:10.1038/nbt0103-32 · Cited by 159
Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression
Prabha, S., & Labhasetwar, V. D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016250.56402.99 · Cited by 150
Srinivasan, C., Lee, J., Papadimitrakopoulos, F., Silbart, L. K., Zhao, M., & Burgess, D. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.010 · Cited by 131
Selectins—an emerging target for drug delivery
Ehrhardt, C., Kneuer, C., & Bakowsky, U. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.029 · Cited by 130
Okuda, T., Kawakami, S., Akimoto, N., Niidome, T., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.012 · Cited by 128
Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles
Wartlick, H., Spänkuch-Schmitt, B., Strebhardt, K., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.029 · Cited by 123
Techniques: New approaches to the delivery of biopharmaceuticals
Orive, G., Rodríguez‐Gascón, A., Hernández, R. M., Domínguez‐Gil, A., & Pedraz, J. L. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.006 · Cited by 112
Cellular Fate of a Modular DNA Delivery System Mediated by Silica Nanoparticles
Gemeinhart, R. A., Luo, D., & Saltzman, W. M. (2005) · Biotechnology Progress · doi:10.1021/bp049648w · Cited by 108
Dextran−Gold Nanoparticle Hybrid Material for Biomolecule Immobilization and Detection
Lee, S., & Pérez-Luna, V. H. (2005) · Analytical Chemistry · doi:10.1021/ac050484n · Cited by 92
Thrall, J. H. (2004) · Radiology · doi:10.1148/radiol.2302031698 · Cited by 89
Calls Rise for More Research on Toxicology of Nanomaterials
Service, R. F. (2005) · Science · doi:10.1126/science.310.5754.1609 · Cited by 80
Cegnar, M., Premzl, A., Zavašnik‐Bergant, V., Kristl, J., & Kos, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.021 · Cited by 72
Anticancer drug delivery with nanoparticles.
(2006) · PubMed · Cited by 68
Dagar, S., Sekosan, M., Lee, B. S., Rubinstein, I., & Önyüksel, H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00326-1 · Cited by 55
Release of DNA from dendriplexes encapsulated in PLGA nanoparticles
Ribeiro, S. J., Hussain, N., & Florence, A. T. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.036 · Cited by 54
Fonseca, M. J., Jagtenberg, J. C., Haisma, H. J., & Storm, G. (2003) · Pharmaceutical Research · doi:10.1023/a:1022608321861 · Cited by 45
Cited by
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Metadata
- Authors
- Liu, Y., Miyoshi, H., & Nakamura, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-04-10
- Volume
- 120
- Issue
- 12
- Pages
- 2527-2537
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2015230924
- Cited by
- 620
- References
- 89
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.